Jenburkt Pharmaceuticals Announces Trading Window Closure
Jenburkt Pharmaceuticals Ltd. announced that its trading window for equity shares will be closed from April 1, 2026, until 48 hours after the release of the company's audited financial results for the quarter and financial year ending March 31, 2026. This closure aligns with the company's code on the prohibition of insider trading and the Securities and Exchange Board of India (SEBI) regulations. A separate announcement regarding the board meeting schedule to review the financial results will be issued in due course. Ashish R. Shah, Senior Vice President and Company Secretary, confirmed the closure.Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.